Genentech refused appeal in Herceptin case

27-05-2014

Genentech refused appeal in Herceptin case

Photo: Africa Studio / Shutterstock.com

Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.


Genentech, Herceptin, Justice Birss, permission to appeal, English High Court

LSIPR